Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Stem Cells International|November 16, 2017
Tissue Source and Cell Expansion Condition Influence Phenotypic Changes of Adipose-Derived Stem CellsLauren H Mangum, Shanmugasundaram Natesan, Randolph Stone, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiformeAllen M Chen, Susan Chang, Jean Pouliot, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant gliomaDavid A Larson, Michael Prados, Kathleen R Lamborn, et al.
Neuro-Oncology|May 12, 2004
Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiformeDavid A Larson, Jeffrey M Suplica, Susan M Chang, et al.
Technology in Cancer Research & Treatment|November 13, 2010
Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapyLijun Ma, Arjun Sahgal, Luca Cozzi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2012
Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practiceArjun Sahgal, Vivian Weinberg, Lijun Ma, et al.
Expert Review of Anticancer Therapy|November 26, 2011
Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practiceGiuseppina Laura Masucci, Eugene Yu, Lijun Ma, et al.
Journal of Neurosurgery|July 2, 2016
Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomesMichael A Garcia, Ann Lazar, Sai Duriseti, et al.
Technology in Cancer Research & Treatment|August 4, 2009
Advances in technology for intracranial stereotactic radiosurgeryArjun Sahgal, Lijun Ma, Eric Chang, et al.
Pageof 7